Coronary Heart Disease Clinical Trials

48 recruiting

Coronary Heart Disease Trials at a Glance

54 actively recruiting trials for coronary heart disease are listed on ClinicalTrialsFinder across 6 cities in 20 countries. The largest study group is Not Applicable with 18 trials, with the heaviest enrollment activity in Beijing, Shenyang, and Zhengzhou. Lead sponsors running coronary heart disease studies include China National Center for Cardiovascular Diseases, China-Japan Friendship Hospital, and La Trobe University.

Browse coronary heart disease trials by phase

Treatments under study

About Coronary Heart Disease Clinical Trials

Looking for clinical trials for Coronary Heart Disease? There are currently 48 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Coronary Heart Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Coronary Heart Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 54 trials

Recruiting
Not Applicable

Closed-Loop Neurofeedback Targeting the Left Dorsolateral Prefrontal Cortex for Cardiac Autonomic Modulation in Coronary Artery Disease With Anxiety

Coronary Heart Disease (CHD)Anxiety Disorders
Shenyang Medical College56 enrolled1 locationNCT07244484
Recruiting
Not Applicable

Closed-Loop Neurofeedback Targeting the Right Dorsolateral Prefrontal Cortex for Cardiac Autonomic Modulation in Coronary Artery Disease With Anxiety

Coronary Heart Disease (CHD)Anxiety Disorders
Shenyang Medical College56 enrolled1 locationNCT07238920
Recruiting
Not Applicable

CORE-COMPARE Pilot Study

Coronary Heart Disease (CHD)
Johns Hopkins University140 enrolled1 locationNCT06170541
Recruiting
Phase 1

A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease

Premature Coronary Heart DiseaseHeterozygous Familial Hypercholesterolemia
Verve Therapeutics, Inc.85 enrolled22 locationsNCT06164730
Recruiting
Not Applicable

A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug-coated Stents and the Xience Drug-eluting Stent System in Patients With Acute Coronary Syndrome and High Bleeding Risk Using Optical Coherence Tomography

Coronary Heart DiseaseAcute Coronary Syndrome
China National Center for Cardiovascular Diseases60 enrolled1 locationNCT07230847
Recruiting
Phase 1Phase 2

A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease

Coronary Heart DiseaseCoronary Artery DiseaseAtheroscleroses
Xia Liang30 enrolled1 locationNCT07493603
Recruiting
Not Applicable

Exercise Training in Women With Heart Disease 2

Cardiovascular DiseasesCoronary Heart Disease
Ottawa Heart Institute Research Corporation172 enrolled1 locationNCT06494163
Recruiting

Glycocalyx and Oxidative Stress in Endothelial Function (Part 2)

Coronary Heart Disease
Josip Juraj Strossmayer University of Osijek35 enrolled1 locationNCT07451873
Recruiting

A Prospective Multicenter Clinical Study: IntracOronary neaR-Infrared Spectroscopy and OptIcal Coherence Tomography for Evaluating Coronary vulNerable Plaque in Patients With diabeTes

Coronary Heart Disease (CHD)Diabetes (DM)
Shanghai Zhongshan Hospital1,516 enrolled1 locationNCT06649305
Recruiting

REsiduAL rISk Under Intensive Lipid-lowering Therapy In Coronary Heart Disease

Coronary Heart Disease (CHD)
Shanghai Zhongshan Hospital900 enrolled1 locationNCT06936111
Recruiting

AI-Driven Dynamic Prediction of Non-Target Lesion Progression After PCI: A Chinese Multicenter Cohort Study

Coronary Heart Disease (CHD)
China-Japan Friendship Hospital12,000 enrolled1 locationNCT07312318
Recruiting
Phase 4

Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction

Coronary Heart Disease
SPH Qingdao Growful Pharmacetical Co.,Ltd2,708 enrolled96 locationsNCT07110415
Recruiting
Not Applicable

Intelligent Management Platform for Guiding Exercise Rehabilitation in Coronary Heart Disease Patients

Secondary Prevention of Coronary Heart Disease
China National Center for Cardiovascular Diseases200 enrolled1 locationNCT07259278
Recruiting
Not Applicable

Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease

Premature Coronary Heart Disease
China National Center for Cardiovascular Diseases4,900 enrolled16 locationsNCT07031531
Recruiting

Clinical Outcomes of Patients With Coronary Artery Disease

Coronary Heart Disease (CHD)
Shenyang Northern Hospital10,000 enrolled1 locationNCT06216847
Recruiting
Phase 4

Effect of Xuesaitong Soft Capsules on Major Risk Factors in Patients With Coronary Heart Disease

Coronary Heart Disease
China National Center for Cardiovascular Diseases240 enrolled2 locationsNCT06425120
Recruiting
Not Applicable

Community Exercise Treating Effect on Cardiopulmonary Disease Patients

Heart FailureCardiomyopathyCoronary Heart Disease (CHD)+5 more
Guangdong Provincial People's Hospital200 enrolled1 locationNCT07154355
Recruiting

Village-Based Management of Chronic Cardiovascular Disease in Qu Jiang Elderly Population Registry: The BOUQUET Cohort Study

Heart FailureHypertensionCoronary Heart Disease (CHD)+1 more
Beijing Anzhen Hospital30,000 enrolled1 locationNCT07149688
Recruiting
Phase 2

Study of Sivelestat Sodium in OPCABG

Coronary Heart DiseaseCoronary Artery DiseaseCoronary Arterial Disease (CAD)
Affiliated Hospital of Nantong University62 enrolled1 locationNCT07118930
Recruiting
Not Applicable

Feasibility of Innovative Approaches for Personalized Cardiovascular Prevention

Coronary Heart Disease
Catholic University of the Sacred Heart120 enrolled7 locationsNCT06911294